FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia - Summary - MDSpire

FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia

Deseyne delivers smooth, continuous focus across near, intermediate, and distance vision, which is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner.

  • By

  • Conexiant News Staff

  • January 4, 2026

  • 2 min

Share

Objective:

To announce the FDA clearance of the first daily disposable soft contact lens for presbyopia using extended depth of focus technology.

Key Findings:
  • Deseyne offers a depth of focus comparable to FDA-approved EDOF intraocular lenses.
  • Clinically meaningful improvements in near and intermediate vision have been reported.
  • The lens is manufactured from vifilcon C hydrogel and includes components for hydration and comfort.
Interpretation:

The introduction of Deseyne represents a significant advancement in non-surgical options for managing presbyopia, potentially improving patient quality of life.

Limitations:
  • The article does not provide specific clinical trial data or outcomes from US-based studies.
  • Long-term effects and performance in diverse populations are yet to be established.
Conclusion:

Deseyne's FDA clearance marks a pivotal development in presbyopia management, expanding options for patients seeking non-surgical solutions.

Original Source(s)

FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia

  • by Conexiant News Staff

  • January 4, 2026

Related Content

Reviewing the Risks of Orthokeratology

Floaters May Signal Higher Risk Than Flashes

New study examines retinal detachment risk in primary care presentations

Women Prefer Contact Lens Under-Correction

Clinic-based study suggests sex differences in preferred contact lens under-correction during presbyopia management